The FDA suggests that American women are not eating enough fish, though consumers still need to be mindful of which fish to avoid.
©Jacek Chabraszewski - stock.adobe.com
The US Food and Drug Administration (FDA) has issued new information for women on eating fish. The document updates advice issued jointly by FDA and the US Environmental Protection Agency (EPA) in 2017.
The advice categorizing fish based on their mercury levels has not changed but the update further promotes science-based recommendations in Dietary Guidelines for Americans on the importance of fish in healthy eating patterns. FDA/EPA advice has been expanded and fish and shellfish now are referred to collectively as “fish” in text and a chart that highlight:
According to the Guidelines, people in the United States aged 2 years and older and adults should eat at least 8 oz of seafood (less for young children) each week based on a 2,000-calorie diet. Women who are pregnant or breastfeeding should eat between 8 and 12 oz of lower-mercury fish per week. FDA notes that fish consumption in the United States is far less than these amounts.
FDA’s “Advice about Eating Fish” includes a chart of best and good fish choices, and choices to avoid. Among the “best” choices are canned light tuna, flounder, and shrimp, whereas fish that should be avoided include orange roughy and bigeye tuna.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More